Referred Tests
Accurate and dependable testing.
Reliable interpretation of dynamic results
Accurate and dependable endocrine function testing is one of the cornerstones of the Mayo Clinic practice. Standardization of procedures and protocols is essential for the reliable interpretation of dynamic endocrine testing results. Our test menu includes more than 70 common and esoteric analytes and is constantly growing. We strive to use the best-suited methodology for every test, ranging from manual immunoassays over mass spectrometry to molecular testing.
Results that matter
We're dedicated to our patients' health and well-being,
and proud of the outstanding outcomes we achieve.
#1
ranked hospital in the nation for adult diabetes and endocrinology by U.S. News and World Report
40+
clinical endocrinologists on staff at Mayo Clinic
70+
endocrine-specific tests in our comprehensive test menu
24/7
support from Mayo Clinic physicians and scientists
Answers when you need them
We perform testing daily for Mayo Clinic patients in addition to providing services to hospitals across the globe. We focus on turnaround time — not just transit time — to ensure providers and patients get the answers they need as quickly as possible.
Performing the right tests, not the most tests
We are a health care provider, treating patients every day. Our laboratory services enable health care institutions to apply patient care-driven testing approaches and establish clinically proven test utilization strategies.
Access to Mayo Clinic expertise
The Endocrine Laboratory within Mayo Clinic is one of the leading endocrine testing facilities in the United States, with a track record of excellence for several decades. Its achievements include development of the first commercially available immunometric whole molecule parathyroid hormone assay; pioneering work in establishing steroid and vitamin D testing by mass spectrometry; and co-development of several widely used immunoassays in the in vitro diagnostic industry.
The latest
In this month’s “Hot Topic,” Rondell Graham, M.B.B.S., provides an overview of a PRKACA FISH test that assists in differentiating fibrolamellar carcinoma from other subtypes of primary liver cancer.
Understanding the difference between benign and malignant adrenal tumors has always been difficult, but the new Urinary Steroid Profile assay will assist with this medical challenge.
This week’s Research Roundup highlights the association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer.
This week’s Research Roundup highlights the association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer.
According to Mayo Clinic research published in JAMA, six genes contain mutations that may be passed down in families, substantially increasing a person’s risk for pancreatic cancer.